6505--Revlimid, Pomalyst, Camzyos Specialty Pharmaceuticals 36C25226N0198
Summary
AI-generated · Jan 07, 2026Contract awarded for Revlimid, Pomalyst, and Camzyos specialty pharmaceuticals; Bristol-Myers Squibb Company is the awardee, with a contract value of $848,445.
Notice history
1Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| Bristol-Myers Squibb Company | UFGKB2B71N12 | 4K2D9 | LAWRENCEVILLE |
Contacts
Contracting Officer
Phone